Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hershey Co (HSY) vs Philip Morris International Inc. (PM) Price & Performance

Hershey CoTrade
Philip Morris International Inc.Trade

Price performance (Past 24H)

Key statistics

Hershey Co vs Philip Morris International Inc. — how do they compare? Hershey Co trades at $162.52 (market cap $32.66B), while Philip Morris International Inc. trades at $199.8 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 9.6× Hershey Co's market cap, and Hershey Co pays the higher dividend (3.57%). Which is the better fit depends on your goals — on Pluang, investors hold Hershey Co for 135 Days and Philip Morris International Inc. for 85 Days on average.

HSYPM
Market Cap
$32.66B$312.50B
Volume
1,578,2375,517,172
Sector
Consumer StaplesConsumer Staples
52-Week High
$236.28$200.50
52-Week Low
$157.61$144.33
Typical Hold Time
135 Days85 Days
Enterprise Value
$37.79B$355.62B
Dividend Yield
3.57%3.19%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hershey Co

Hershey (HSY) trades at $160.34, down 0.29% on the day, with a bearish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Strong profitability metrics include a 32.81% ROE and 12.24% net margin, though 2025 net income declined significantly from 2024 levels. Recent corporate developments include new international leadership and ongoing brand investment initiatives.

The stock presents a mixed outlook with 26% upside to the consensus price target of $204.62, but faces headwinds from cocoa cost pressures and technical weakness. While dividend growth has resumed after a nearly two-year freeze, investors should weigh strong brand positioning against commodity volatility and declining institutional holdings in recent quarters.

Philip Morris International Inc.

Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.

Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HSY
100% Buy0% Sell
Avg holding period · 135 Days
PM
10% Buy90% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About Hershey Co

Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.

Read more on HSY →

About Philip Morris International Inc.

Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.

Read more on PM →